HBV-IN-4 is a potent, orally bioavailable phthalazinone derivative that inhibits HBV replication with an IC50 of 14 nM by promoting the assembly of genome-free capsids. This mechanism supports its investigation in both cellular and animal models of hepatitis B infection.
Molekulargewicht:
479.89
CAS Nummer:
[2305897-84-9]
Formel:
C24H19ClFN5O3
Target-Kategorie:
HBV,DNA/RNA Synthesis,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten